Adherence to treatment in asthma and COPD patients in their doctors’ assessment

Pneumonologia i Alergologia Polska

Volumn 83, Issue 6, 2015, Pages 436-444

  Kardas, Przemysław ^a   Lewek, Paweł ^a   Strzondała, Marcin ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Asthma; Compliance; COPD; Non adherence

Indexed keywords

ASTHMA; DISEASE MANAGEMENT; GENERAL PRACTICE; HUMAN; MEDICATION COMPLIANCE; PATIENT ATTITUDE; POLAND; PRESCRIPTION; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICS AND NUMERICAL DATA;

ASTHMA; DISEASE MANAGEMENT; DRUG PRESCRIPTIONS; FAMILY PRACTICE; HUMANS; MEDICATION ADHERENCE; PATIENT ACCEPTANCE OF HEALTH CARE; POLAND; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84946732717     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: 10.5603/PiAP.2015.0072     Document Type: Article

References (36)

1. Vrijens B, De Geest S, Hughes DA et al. ABC Project Team. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 2012; 73: 691–705. doi: 10.1111/j.1365-2125.2012.04167.x.
2. Adherence to long-term therapies. Evidence for action. World Health Organisation 2003.
3. Kardas P. Rozpowszechnienie nieprzestrzegania zaleceń terapeutycznych wśród pacjentów leczonych z powodu wybranych schorzeń przewlekłych. Pol Merk Lek 2011; 184: 215–220.
4. To T, Stanojevic S, Moores G. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health 2012; 12: 204. doi: 10.1186/1471-2458-12-204.
5. Vos T, Flaxman AD, Naghavi M et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2163–2196. doi: 10.1016/S0140-6736(12)61729-2.
6. Bourdin A, Halimi L, Vachier I et al. Adherence in severe asthma. Clin Exp Allergy 2012; 42: 1566–1574. doi: 10.1111/j.1365-2222.2012.04018.x.
7. Bender BG, Rand C. Medication non-adherence and asthma treatment cost. Curr Opin Allergy Clin Immunol 2004; 4: 191–195.
8. Robinson DS, Campbell DA, Durham SR, Pfeffer J, Barnes PJ, Chung KF. Systematic assessment of difficult-to-treat asthma. Eur Respir J 2003; 22: 478–483.
9. Williams LK, Pladevall M, Xi H et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 2004; 114: 1288–1293.
10. Cooke CE, Sidel M, Belletti DA, Fuhlbrigge AL. Review: clinical inertia in the management of chronic obstructive pulmonary disease. COPD 2012; 9: 73–80. doi: 10.3109/15412555.2011.631957.
11. Restrepo RD, Alvarez MT, Wittnebel LD et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis 2008; 3: 371–384.
12. Kardas P, Ratajczyk-Pakalska E. Świadomość problemu niestosowania się pacjentów do zaleconej terapii wśród lekarzy podstawowej opieki zdrowotnej regionu łódzkiego. Polska Med Rodz 2000; 2: 151–157.
13. Mäkelä MJ, Backer V, Hedegaard M, Larsson K. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir Med 2013; 107: 1481–1490. doi: 10.1016/j.rmed.2013.04.005.
14. Haupt D, Krigsman K, Nilsson JL. Medication persistence among patients with asthma/COPD drugs. Pharm World Sci 2008; 30: 509–514. doi: 10.1007/s11096-008-9197-4.
15. Huetsch JC, Uman JE, Udris EM, Au DH. Predictors of adherence to inhaled medications among Veterans with COPD. J Gen Intern Med 2012; 27: 1506–1512. doi: 10.1007/s11606-012-2130-5.
16. Jung E, Pickard AS, Salmon JW, Bartle B, Lee TA. Medication adherence and persistence in the last year of life in COPD patients. Respir Med 2009; 103: 525–534. doi: 10.1016/j.rmed.2008.11.004.
17. Kardas P, Czeleko T, Śliwczyński A. Ciągłość i systematyczność leczenia astmy i POChP w Polsce — ocena przestrzegania zaleceń terapeutycznych na podstawie analizy krajowej bazy danych realizacji recept. Proceedings of The 10th International Conference of the Polish Pharmacoeconomics Society — ISPOR Poland Chapter, Warsaw, 2012.
18. Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol 2013; 4: 91. doi: 10.3389/fphar.2013.00091.
19. DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: A meta-analysis. Med Care 2007; 45: 521–528.
20. Menckeberg TT, Bouvy ML, Bracke M, Hugtenburg JG, Lammers JW, Raaijmakers JA. Patients’ understanding of the reasons for starting and discontinuing inhaled corticosteroids. Br J Clin Pharmacol 2008; 66: 255–260. doi: 10.1111/j.1365-2125.2008.03168.x.
21. Krigsman K, Moen J, Nilsson JL, Ring L. Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period. J Clin Pharm Ther 2007; 32: 603–611.
22. Le TT, Bilderback A, Bender B et al. Do asthma medication beliefs mediate the relationship between minority status and adherence to therapy? J Asthma 2008; 45: 33–37. doi: 10.1080/02770900701815552.
23. Sondaż TNS OBOP dla Wiadomości 09.10.2012, http://tvp.info/informacje/polska/co-czwartego-pacjenta-nie-stac-na-leki/8759289.
24. Zeller A, Taegtmeyer A, Martina B, Battegay E, Tschudi P. Physicians’ ability to predict patients’ adherence to antihypertensive medication in primary care. Hypertens Res 2008; 31: 1765–1771. doi: 10.1291/hypres.31.1765.
25. Lareau SC, Yawn BP. Improving adherence with inhaler therapy in COPD. Int J Chron Obstruct Pulmon Dis 2010; 24: 401–406. doi: 10.2147/COPD.S14715.
26. George J, Kong DC, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest 2005; 128: 3198–3204.
27. Bender B, Wamboldt FS, O’Connor SL et al. Measurement of children’s asthma medication adherence by self report, mother report, canister weight, and Doser CT. Ann Allergy Asthma Immunol 2000; 85: 416–421.
28. Barnestein-Fonseca P, Leiva-Fernández J, Vidal-España F, García-Ruiz A, Prados-Torres D, Leiva-Fernández F. Is it possible to diagnose the therapeutic adherence of patients with COPD in clinical practice? A cohort study. BMC Pulm Med 2011; 11: 6. doi: 10.1186/1471-2466-11-6.
29. Rand C. “I took the medicine like you told me, doctor”: Self- report of adherence with medical regimens. In: Stone AA, Turkkan JS, Bachrach CA et al. (eds.) The science of self-report: Implications for research and practice. Mahwah, NJ: Lawrence Erlbaum 1999; 257–276.
30. Krigsman K, Nilsson JL, Ring L. Adherence to multiple drug therapies: refill adherence to concomitant use of diabetes and asthma/COPD medication. Pharmacoepidemiol Drug Saf 2007; 16: 1120–1128.
31. Stoloff SW, Stempel DA, Meyer J, Stanford RH, Carranza Rosenzweig JR. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J Allergy Clin Immunol 2004; 113: 245–251.
32. Fenton C, Keating GM. Inhaled salmeterol/fluticasone propionate: a review of its use in chronic obstructive pulmonary disease. Drugs 2004; 64: 1975–1996.
33. Price D, Robertson A, Bullen K, Rand C, Horne R, Staudinger H. Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study. BMC Pulm Med 2010; 10: 1. doi: 10.1186/1471-2466-10-1.
34. Toy EL, Beaulieu NU, McHale JM et al. Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs. Respir Med 2011; 105: 435–441. doi: 10.1016/j.rmed.2010.09.006.
35. Claxton AJ, Cramer J, Pierce C. A systematic review of the association between dose regimens and medication compliance. Clin Ther 2001; 23: 1296–1310.
36. Główny Urząd Statystyczny. Rocznik statystyczny Rzeczypospolitej Polskiej 2013. Warszawa 2013.